80
Participants
Start Date
March 29, 2018
Primary Completion Date
August 3, 2020
Study Completion Date
September 10, 2020
Ondansetron
Ondansetron is a highly selective receptor antagonist (5-HT3RA)
Barnsley Hospital NHS Foundation Trust, Barnsley
Sandwell and West Birmingham Hospitals NHS Trust, Birmingham
County Durham and Darlington NHS Foundation Trust, Durham
Westen General Hosptal, Edinburgh, Edinburgh
Leeds Teaching Hospitals NHS Trust, Leeds
London North West NHS Foundation Trust, London
Queen Mary, University of London, London
University College London Hospitals NHS Foundation Trust, London
Salford Royal Hospital, Manchester
University Hospital of South Manchester, Manchester
SouthTees Hospitals NHS FoundationTrust, Middlesbrough
Nottingham University Hospitals NHS Trust, Nottingham
Royal Hallamshire Hospital, Sheffield
University Hospitals of North Midlands NHS Trust, Stoke
Barnsley Hospital NHS Foundation Trust
OTHER
Barts & The London NHS Trust
OTHER
County Durham and Darlington NHS Foundation Trust
OTHER_GOV
Flinders University
OTHER
The Leeds Teaching Hospitals NHS Trust
OTHER
London North West Healthcare NHS Trust
OTHER
NHS Lothian
OTHER_GOV
Queen Mary University of London
OTHER
Sandwell & West Birmingham Hospitals NHS Trust
OTHER
Sheffield Teaching Hospitals NHS Foundation Trust
OTHER
University College London Hospitals
OTHER
University Hospitals of North Midlands NHS Trust
OTHER
Manchester University NHS Foundation Trust
OTHER_GOV
University of Manchester
OTHER
National Institute for Health Research, United Kingdom
OTHER_GOV
University of Leeds
OTHER